Involvement of the <scp>OTUB1‐YAP1</scp> axis in driving malignant behaviors of head and neck squamous cell carcinoma

  • Shengjian Jin
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Takaaki Tsunematsu
    Department of Oral Molecular Pathology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Taigo Horiguchi
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Yasuhiro Mouri
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Wenhua Shao
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Keiko Miyoshi
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Hiroko Hagita
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Motoharu Sarubo
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Natsumi Fujiwara
    Department of Oral Healthcare Management Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Guangying Qi
    Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation Guilin Medical University Guilin China
  • Naozumi Ishimaru
    Department of Oral Molecular Pathology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan
  • Yasusei Kudo
    Department of Oral Bioscience Tokushima University Graduate School of Biomedical Sciences Tokushima Japan

Search this article

Description

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Comprehending the molecular mechanisms underlying head and neck squamous cell carcinoma (HNSCC) is vital for the development of effective treatment strategies. Deubiquitinating enzymes (DUBs), which regulate ubiquitin‐dependent pathways, are potential targets for cancer therapy because of their structural advantages. Here we aimed to identify a potential target for HNSCC treatment among DUBs.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A screening process was conducted using RNA sequencing data and clinical information from HNSCC patients in the TCGA database. A panel of 88 DUBs was analyzed to identify those associated with poor prognosis. Subsequently, HNSCC cells were modified to overexpress specific DUBs, and their effects on cell proliferation and invasion were evaluated. In vivo experiments were performed to validate the findings.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In HNSCC patients, USP10, USP14, OTUB1, and STAMBP among the screened DUBs were associated with a poor prognosis. Among them, OTUB1 showed the most aggressive characteristics in both in vitro and in vivo experiments. Additionally, OTUB1 regulated the stability and nuclear localization of YAP1, a substrate involved in cell proliferation and invasion. Notably, OTUB1 expression exhibited a positive correlation with the HNSCC‐YAP score in HNSCC cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>This study highlights the critical role of OTUB1 in HNSCC progression via modulating YAP1. Targeting the OTUB1‐YAP1 axis holds promise as a potential therapeutic strategy for HNSCC treatment.</jats:p></jats:sec>

Journal

References(47)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top